Altre lingue Scancell Holdings plc

Azioni

Mercato chiuso - London S.E. Altri mercati azionari 17:35:09 04/07/2024			Variaz. 5gg	Var. 1 gen.
10,25 ^GBX	0,00%		-7,87%	-2,38%

02/07	Creo estende il contratto; Belluscura raccoglie fondi	AN
02/07	Scancell proroga le date di rimborso delle note di prestito convertibili	MT

Creo extends contract; Belluscura raises funds	02/07
Scancell Extends Redemption Dates of Convertible Loan Notes	02/07
Shares in Scancell climb as strikes exclusive drug evaluation deal	12/06
Scancell Gets UK Approval to Add Expansion Cohort to Cancer Vaccine Trial	30/05
Scancell Holdings Receives MHRA Approval To Expand Modify Trial	30/05
Scancell Holdings plc Provides Update on ModiFY Trial	30/05
Scancell : Interim Report 31st October 2023	21/05
Scancell doses first patient in melanoma-focused trials	26/03
Seneca Growth Capital announces tepid 2023 results	22/03
Scancell Holdings plc Appoints Sath Nirmalananthan to the Board	14/03
Alliance Pharma appoints chair; FireAngel sales down	05/02
Scancell's Chief Development Officer to Step Down	05/02
Scancell Holdings plc Directorate and Executive Changes Changes	05/02
Scancell interim loss narrows amid finance gain on derivative	30/01
Scancell Holdings plc Reports Earnings Results for the Half Year Ended October 31, 2023	30/01
Scancell approved by MHRA to add new cohort to Scope trial	17/01
Scancell Holdings plc Announces Update on SCOPE Trial	17/01
Scancell Raises GBP1.2 Million Via Open Offer	19/12
Scancell raises GBP12 million in total from fundraise	19/12
Scancell Raises GBP11 Million via Share Issue	01/12

Non ci sono risultati per questa ricerca